Dermatological guidelines for monitoring methotrexate treatment reduce drug-survival compared to rheumatological guidelines.

Dermatological guidelines for monitoring methotrexate treatment reduce drug-survival compared to rheumatological guidelines.

Methotrexate (MTX) is widely used as disease modifying treatment for psoriasis and psoriatic arthritis (PsA). Rheumatological and dermatological guidelines to prevent MTX-induced adverse events diverge in the number and frequency of blood tests. These differences are not based on evidence indicating...

Full description

Bibliographic Details
Main Authors: Felien T M Busger Op Vollenbroek, Carine J M Doggen, René W A Janssens, Hein J Bernelot Moens
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2018-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC5865732?pdf=render

Internet

http://europepmc.org/articles/PMC5865732?pdf=render

Similar Items